Users online: 4231     
Email id

Year : 2018, Volume : 19, Issue : 1
First page : ( 91) Last page : ( 93)
Print ISSN : 0972-1738. Online ISSN : 2249-8796.

Clinical evaluation of lithium antimony thiomalate against papillomatosis in bovines and canines

Satheesha S.P.*, Chandrashekhar G., Dhanalakshmi S., Kottadamane M.R.

Department of Teaching Veterinary Clinical Complex, Veterinary College Karnataka Veterinary, Animal and Fisheries Sciences University (KVAFSU), Vinobha Nagar, Shivamogga-577204 (Karnataka)

*Assistant Professor and Corresponding author. E-mail: satish.vet@rediffmail.com

Online published on 5 November, 2018.


The study was conducted to evaluate efficacy of Lithium antimony thiomalate on bovine and canine papillomatosis. A total of nineteen (19) cattle and eleven (11) dogs were enrolled for the study. In cattle, lesions were majorly observed on teats and udder, over frontal and muzzle region and occasionally over ventral and dorsal aspect of abdomen. Whereas in dogs, the cauliflower like growths or warts of varied sizes (5-10mm) were present on multiple sites including skin of face, periocular region, ventral mandibular region, muco-cutaneous junction of upper and lower lip and on dorsal and ventral aspects of tongue. Amongst the treated cattle, none of the animals showed complete wart regression indicating lowered efficacy of Anthiomaline in bovine papillomatosis. In canine papillomatosis, the efficacy was highly encouraging among all treated dogs with complete clinical recovery within 3–4 weeks indicating 100 percent results.



Bovine, canine, papillomatosis, lithium antimony thiomalate.


║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
379,481,345 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.